C
Carmelo Lafuente-Lafuente
Researcher at University of Paris
Publications - 55
Citations - 1391
Carmelo Lafuente-Lafuente is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 14, co-authored 46 publications receiving 1128 citations. Previous affiliations of Carmelo Lafuente-Lafuente include Pierre-and-Marie-Curie University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
TL;DR: Several class IA, IC and III drugs, as well as class II drugs (beta-blockers), are moderately effective in maintaining sinus rhythm after conversion of atrial fibrillation, but they increase adverse events and are associated with increased all-cause mortality.
Journal ArticleDOI
Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
Carmelo Lafuente-Lafuente,Stéphane Mouly,Miguel Angel Longás-Tejero,Isabelle Mahé,Jean-François Bergmann +4 more
TL;DR: Class IA, IC, and III drugs are effective in maintaining sinus rhythm but increase adverse effects, and class IA drugs may increase mortality.
Journal ArticleDOI
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
Nick Freemantle,Carmelo Lafuente-Lafuente,Stephen Mitchell,Laurent Eckert,Matthew R. Reynolds +4 more
TL;DR: Amiodarone has been demonstrated to be the most effective drug in maintaining sinus rhythm and increasing mortality and dronedarone possibly decreasing the incidence of serious adverse events and proarrhythmia.
Journal ArticleDOI
Active chest compression-decompression for cardiopulmonary resuscitation.
TL;DR: Active chest compression-decompression in patients with cardiac arrest is not associated with clear benefit and assessment of neurological outcome was limited and there were few patients with neurological damage.
Journal ArticleDOI
Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity.
Carmelo Lafuente-Lafuente,Jean-Claude Alvarez,Antoine Leenhardt,Stéphane Mouly,Fabrice Extramiana,Charles Caulin,Christian Funck-Brentano,Jean-François Bergmann +7 more
TL;DR: No evidence of excessive or unexpected accumulation of amiodarone in fat tissue on long-term administration is found, and late amioarone adverse effects, particularly hypothyroidism, are associated with longer exposure times, but do not seem to be explained by higher concentrations in plasma or infat tissue.